Indices of angiogenesis are increased in synovia from patients with arthritis, and vascular proliferation may contribute to the pathogenesis of synovitis, pannus growth, bone and cartilage destruction, and osteophyte formation. Pharmacological inhibition of angiogenesis therefore has potential as a therapeutic strategy in human arthritis. However, vascular growth is also essential for normal development, female reproduction and tissue repair. Selective inhibition of undesirable angiogenesis requires an understanding of the different regulatory mechanisms in pathological and physiological angiogenesis. This review outlines the evidence that the rate of angiogenesis is increased in the inflamed human synovium, and possible approaches to, and consequences of, the modulation of vascular growth.
Angiogenesis is a complex process through which new have recently been described as modulators of angiogenesis that act through Tie-2 receptors on endothelial cells blood vessels grow from a pre-existing vasculature. It is an essential component of the normal female reproduct- [51, 52] . A role for angiopoietins in arthritis has not been defined yet. This large number of factors ive cycle, embryogenesis, growth and successful tissue repair. In other circumstances, however, angiogenesis is may indicate redundancy in angiogenic pathways. Alternatively, different factors may regulate angiogenesis damaging to the organism, contributing to blindness in diabetic retinopathy, and facilitating growth and metaduring different phases of synovitis, in different tissues, and in different physiological and pathological condistasis of tumours. Rheumatoid arthritis (RA) has been thought of as an angiogenesis-dependent disease, raising tions. This diversity of regulatory pathways may permit the targeted manipulation of pathological angiogenesis. hopes that pharmacological inhibitors of angiogenesis may provide novel approaches to disease suppression This review outlines the evidence that the rate of angiogenesis is increased in human arthritis, and possible [1, 2] .
Angiogenesis is a process, rather than a single event. approaches to, and consequences of, the modulation of vascular growth. Endothelial cell proliferation and migration are followed by capillary tube formation, deposition of basement membrane, and proliferation and migration of pericytes Vascular turnover is increased in human and smooth muscle cells. Anastomoses are created and synovitis blood flow is established. There then follows a protracted period of vascular reorganization. Redundant vessels Endothelial cell proliferation is required for sustained regress, a process which requires endothelial cell angiogenesis [53] . Markers of endothelial cell proliferaapoptosis [3, 4] . Appropriate vessels develop vasoregulation are upregulated in rheumatoid synovitis, consistent tory systems through the expression of vasoactive pepwith increased vascular growth. Endothelial cells within tides and their receptors [5, 6 ] . The desirable end chronically inflamed synovia express early activation product is a microvascular bed whose function matches, genes such as c-myc and c-fos [54] . They express prolifand is responsive to, changes in local metabolic eration markers such as Ki67 antigen, proliferating cell requirements.
nuclear antigen and nuclear organizer regions [55] [56] [57] [58] [59] [60] . Each stage in this complex process can be subject to
[3H ]Thymidine is incorporated into endothelial cells in positive and negative regulation by a wide range of synovial explants from patients with RA, and in experifactors, many of which are present in normal or inflamed mental synovitis in animals [61] [62] [63] . Indices of endothelsynovia (Table 1) . Modulators of angiogenesis continue ial cell proliferation are increased in inflamed human to be discovered. For example, angiopoietins-1 and -2 synovium to levels observed in tumours and healing wounds. Microvessels in inflamed synovia resemble newly 38] Hyaluronic acid (high molecular weight) [38, 50] aAngiogenic factors are subclassified as those that are generated or released during acute inflammation, and those more typically associated with chronic inflammation.
bReferences in square brackets give evidence of the presence of each factor in synovium or synovial fluid, and evidence of angiogenic or anti-angiogenic activity.
formed blood vessels. They frequently lack ancillary cells such as pericytes and smooth muscle cells, and focally express increased amounts of matrix metalloproteinases, E-selectin and integrin a v b 3 [59, 64, 65] . These molecules not only characterize immature endothelia, but may also be required for angiogenesis to proceed [45, 66, 67] . Like proliferating endothelial cells, microvessels in inflamed synovia often express low levels of angiotensin converting enzyme [11, 68] . Newly formed vessels are associated with incomplete vasoregulatory systems [5] . Chronically inflamed synovia contain blood vessels that lack nerves and receptors for vasoregulatory neuropeptides such as substance P [9, 69] .
None of these observations alone is conclusive of fore, that rheumatoid synovitis may persist for many years with little overall change in synovial volume or vascular density (Fig. 1) [70, 71] . the finding that endothelial cell death, a necessary process during vascular regression, is increased in rheumaThe normal synovium is highly vascular, both in man and in animals, satisfying the metabolic demands of the toid synovitis [59] . Samples of synovia which displayed increased endothelial cell expression of proliferation avascular cartilage [70, 72] . In particular, the synovial lining region is associated with a dense microvascular markers also displayed increased labelling of DNA fragments in endothelial cells by terminal uridyldeoxynunetwork. Detailed morphometric studies have indicated that rheumatoid synovitis may result in a reduced vascucleotide nick-end labelling (TUNEL). Evidence of angiogenesis and vascular regression was found in different lar density within 50 mm of the synovial surface [70, 71] . There is a redistribution of blood vessels and increased microscopic foci of the same synovial samples. Increased rates of vascular turnover in rheumatoid synovitis may vascular density in the deeper synovium [70, 73] . These changes in microvascular architecture, as well as defects exceed the capacity of vasoregulatory systems to develop, resulting in a qualitatively abnormal microvasin vasoregulation, may contribute to pockets of hypoxia and increased anaerobic metabolism in chronically culature, without large increases in vascular density. Angiogenesis in the inflamed joint represents a balance inflamed synovia [74, 75] .
A solution to the apparent paradox of increased between the effects of angiogenic and anti-angiogenic factors ( Table 1) . Although angiogenic and antiangiogenesis and decreased vascular density came from angiogenic factors are each expressed, they are localized Angiogenesis and inflammation to separate microscopic foci within chronically inflamed Much has been written about the possible causal links human synovia [59] . Microvessels that display vascular between angiogenesis and chronic inflammation [1, 84] . endothelial growth factor ( VEGF ) and integrin a v b 3 Although chronic inflammation is almost always accomimmunoreactivities also express markers of cellular propanied by angiogenesis, angiogenesis can occur in the liferation, whereas other non-proliferating vessels absence of inflammation. Animal models of angiogenesis express the anti-angiogenic factor thrombospondin.
in the rabbit cornea and chick chorioallantoic membrane Angiogenic and anti-angiogenic factors, endothelial have been developed in order to study angiogenesis in cell survival factors and stimulators of endothelial cell the absence of inflammation. These models can be used death each regulate vascular density during chronic to distinguish factors that directly increase angiogenesis inflammation.
from those that do so by inducing the generation of angiogenic agents by infiltrating inflammatory cells.
Data from animal models clearly demonstrate that angioSites of angiogenesis in arthritis genesis by itself does not necessarily cause inflammation. Indeed, it may be argued that successful angiogenesis The above discussion has focused on the synovium as a during wound healing contributes to the resolution of site of angiogenesis in RA. Vascular densities are not inflammation. uniform throughout the normal synovium [72] . The
Under some circumstances, angiogenesis may potennumber of blood vessels is typically greatest near to the tiate or perpetuate inflammation, rather than cause it. synovial surface. Other sites are also highly vascular, Newly formed blood vessels have increased permeability such as the surfaces of tendons and ligaments, and the to macromolecules, facilitating oedema formation [85] . junctions between synovium, capsule, articular cartilage
The neovasculature also expresses increased levels of and bone (entheses). The highly vascular interface some adhesion molecules such as E-selectin that can between articular cartilage and synovium may be parpermit the migration of inflammatory cells [65, 86, 87] . ticularly important in the angiogenesis associated with Neural and peptide regulatory factors modulate the formation of pannus. New synovial tissue grows inflammation in the mature vasculature, and deficiencies over the articular surface and erodes into the cartilage in these regulatory pathways in the neovascular bed and underlying bone, contributing to joint destruction.
could result in inappropriate inflammation [5] . The close The articular cartilage itself is avascular in the normal, association between angiogenesis and inflammation is mature joint [76 ] . Vascularization of articular cartilage highlighted by the often dual functionality of angiogenic would compromise its biomechanical properties and factors. VEGF was originally described as the potent mechanical loading would be expected to compromise inflammogen vascular permeability factor before its vascular function. Cartilage generates a variety of antimitogenic activity on endothelial cells was recognized angiogenic factors that can inhibit its vascularization [88] . The neovasculature may facilitate the immigration [77, 78] . During osteoarthritis and RA, new vessels of inflammatory cells that generate angiogenic factors invade the cartilage from the underlying bone, probably which, in turn, further facilitate angiogenesis. in response to perturbations in the balance between angiogenic and anti-angiogenic factors [79, 80] . Angiogenesis within cartilage is also an important comAngiogenesis and tissue repair ponent of enchondral bone formation, observed during Repair of injured tissues typically requires angiogenesis. the development of osteophytes at the margins of Inhibitors of angiogenesis reduce the healing rates of osteoarthritic joints [81] . The growth of blood vessels cutaneous wounds and gastrointestinal ulcers [89, 90] . into damaged intervertebral discs may be comparable Conversely, stimulators of angiogenesis may facilitate to the vascularization of abnormal cartilage [82] .
tissue healing [91, 92] . Hypoxia delays wound healing, Sensory nerves are associated with the neovasculature and relief of hypoxia may be one mechanism by which in human discs, raising the possibility that angiogenesis angiogenesis permits tissue repair. The early stages of may create pathways through which so-called 'degeneraangiogenesis resulting in anastomosed new vessels may tive' diseases can be painful [83] .
not be sufficient for successful repair. Sensory denervation also impairs healing, indicating that intact vasoregulatory systems may be important for wound repair [93] .
Roles of angiogenesis during synovitis
In contrast to its role in tissue repair, angiogenesis has also been implicated in tissue injury. Migrating Angiogenesis may play many different roles during endothelial cells generate proteases that are capable of health and disease. Of possible direct benefit in arthritis degrading articular structures such as cartilage [94] . are positive effects on tissue repair and the relief of However, the direct contribution of blood vessels to hypoxia. On the other hand, angiogenesis may exacertissue destruction may be small compared with that of bate inflammation, synovial proliferation and invasion, fibroblasts and inflammatory cells. Angiogenesis may and osteophyte formation. Of additional concern in the facilitate growth of the invasive synovial pannus, rather development of angiogenesis inhibitors for the treatment than directly leading to that invasive process [1] . Pannus of arthritis are potentially detrimental effects on female reproductive capacity, fetal growth and tissue repair.
has been compared with a neoplastic growth [95] .
Angiogenesis is associated with increased tumour are required to support aerobic metabolism in normal muscle, whereas decreased activity is associated with growth, and reduced tumour cell apoptosis [96 ] . Similarly, angiogenesis was localized to regions of reduced vascular densities [105] . Muscles with low vascular densities perform poorly in sustained activities, inflamed synovia that contained many proliferating and few dying synovial cells [59] .
and deficient muscle angiogenesis may contribute to the weakness and fatiguability associated with the disability Angiogenesis and tissue hypoxia of arthritis. Hypoxia is a potent stimulator of angiogenesis, upreguAngiogenesis and ossification lating genes that are associated with hypoxic response During enchondral ossification, chondrocytes hyperelements, such as that encoding VEGF [97] . The synovtrophy and new blood vessels grow from the perichonium in the inflamed joint is hypoxic and intra-articular drial vascular network, invading the cartilage [106 ] . pressure during exercise can exceed capillary perfusion Osteoblastic activity then commences around the neopressure, further exacerbating local hypoxia [98, 99] agents to inhibit osteophyte formation or reduce disease A wide variety of factors may induce death of vascular progression in inflammatory spinal diseases deserves endothelial cells, including oxidative stress, tumour necfurther study. rosis factor alpha, serine proteases and angiotensin II In summary, angiogenesis may play various roles in [100] [101] [102] [103] [104] . Evidence for the presence of each of these arthritis. In established, persistent synovitis, angiogenfactors has been observed in inflamed joints, suggesting esis may contribute to inflammation, tissue damage, mechanisms by which vascular regression may be stimuosteophyte formation and to altered mechanical characlated alongside vascular growth.
teristics of articular cartilage. Angiogenesis is also a Vascular endothelium requires ancillary cells for its feature of early synovitis in man [114] . In an animal survival and normal function. High vascular densities model of synovitis, early increases in endothelial cell are found adjacent to the normal synovial surface, and proliferation were predictive of subsequent persistence there may be limited scope to increase further the of inflammation, whereas acute synovitis in the absence fraction of tissue volume that is occupied by vascular of angiogenesis was followed by resolution of inflammaendothelium.
tion [115] . Furthermore, the anti-angiogenic agents Tissue oxygenation may be affected by the quality, as TNP-470 and integrin a v b 3 antagonists each protected well as the density, of microvessels. Increased vascular against the development of persistent synovitis in animal turnover is associated with deficient vasoregulatory sysmodels [116-118]. We have speculated that angiogenesis tems [5] . Inability of the microvascular bed to match during early synovitis may contribute to the switch from blood flow to local metabolic requirements could result acute to persistent inflammation by disturbing the deliin persistent tissue hypoxia despite high vascular denscate balance between synovial perfusion and metabolic ities. This may be a particular feature of synovium, demand. whose dense microvascular network serves the metabolic needs of the avascular articular cartilage. Perturbations in microvascular function could contribute to persistence
The pharmacological modulation of of inflammation in the synovium, whereas similar angiogenesis changes would be compatible with repair in other tissues [59] .
The development of pharmacological agents that inhibit angiogenesis offers great potential for dissecting the In contrast to the increased angiogenesis in structures within the inflamed joint, adjacent striated muscles roles of angiogenesis in synovitis, and hopes for treating human arthritis. To demonstrate the importance of typically atrophy. Continued, recurrent electrical activity is required to maintain the high vascular densities that angiogenesis in synovitis, agents are required whose sole action is to inhibit angiogenesis. For clinical theraSpecificity of angiogenesis inhibitors peutics, the agents should improve outcome with minAngiogenesis inhibitors developed to date often lack imal adverse events. Much progress has been made specificity, such that it is difficult to attribute improved towards the development of effective and safe pharmacooutcomes to inhibition of angiogenesis. Inhibitors of logical tools. Despite these advances, difficulties still angiogenesis may modify other biological processes, exist in the measurement of appropriate outcomes and independently of their effect on angiogenesis, and they the specificity of agents as inhibitors of angiogenesis.
may have different effects on the angiogenesis associated with different physiological and pathological conditions or in different tissues.
Outcomes of angiogenesis inhibition
Many slow-acting anti-rheumatic agents currently in Since angiogenesis is a process rather than a single use for the treatment of RA can inhibit angiogenesis. event, it cannot be adequately described by a single Gold, penicillamine, sulphasalazine, methotrexate and quantity. Measures of the earliest stages of angiogenesis, antimalarials each can reduce endothelial cell prolifere.g. endothelial cell proliferation indices, do not necesation in vitro, and inhibit angiogenesis in vivo [126] [127] [128] [129] [130] [131] . sarily predict the formation of fully functional vessels.
Other compounds currently under development for the Indices of later stages of angiogenesis, e.g. vascular treatment of arthritis may also inhibit angiogenesis. densities, are affected by a wide variety of processes, Examples include metalloproteinase inhibitors and including vascular regression and the proliferation, infilcytokine antagonists [132, 133] . Non-steroidal antitration and death of non-vascular cells. Vascular density inflammatory agents also have anti-angiogenic activity may change little despite other evidence of rapid angioin some in vivo models [84] . Each of these agents genesis [59] .
additionally affects processes not directly related to Studies of angiogenesis inhibitors in inflammatory vascular growth and it is not yet possible to attribute synovitis have focused on changes in vascular density, disease-modifying activity of slow-acting anti-rheumatic a quantity used extensively in the study of angiogenesis agents to inhibition of vascular growth. inhibition in tumours [116, 118, 119] . Tumours differ Several of those compounds that have been developed from synovium, however, in being initially avascular.
as angiogenesis inhibitors can inhibit synovitis in animal As discussed above, changes in vascular density may models. TNP-470 selectively inhibits the proliferation of not be the most important outcome of angiogenesis in endothelial cells, and ameliorates adjuvant and collagen the pathogenesis of synovitis. Reduced expression of arthritides induced experimentally in rats [116, 117] . vasoregulatory systems, mismatching of perfusion and Integrin a v b 3 antagonists also inhibit the arthritis which metabolic demand, and synovial hypoxia each may follows bilateral knee injection with ovalbumin and influence persistent synovitis and may be a target for basic fibroblast growth factor (bFGF ) in pre-immunized angiogenesis inhibition.
rabbits [118] . However, these agents also may have nonClinical outcomes that may be improved by angiogenvascular effects. TNP-470 modulates lymphocyte and esis inhibition include persistent synovial inflammation, osteoclast functions, and integrin a v b 3 is strongly pannus formation, bone erosion, and new bone formaexpressed by lining cells in the chronically inflamed tion. The relevance of any such effects to outcomes synovium [59, 134, 135] . The precise mechanisms important to the patient, such as pain, functional ability through which these agents can inhibit synovitis thereand psychological well-being, requires further study. On fore remain unknown. Thrombospondin, an antithe other hand, outcomes such as changes in joint scores angiogenic agent in many systems, was not found to and acute-phase response may not reflect direct effects inhibit synovitis in rats [119] . However, thrombosponof angiogenesis inhibition, and may be relatively insensidin is a large, multifunctional protein that can even tive indices for measuring response.
promote angiogenesis under some circumstances [39] . Angiogenesis is essential for a variety of beneficial Several studies therefore indicate that inhibition of processes. Potentially adverse clinical outcomes of angioangiogenesis may be a useful therapeutic strategy in genesis inhibition may include delayed skin wound, inflammatory arthritis. However, it is not yet possible fracture and gastrointestinal ulcer healing, infertility, specifically to eliminate angiogenic processes by interteratogenicity and impaired muscle function. Vascular ventions that do not independently modify other comgrowth is important in healing gastrointestinal damage ponents of inflammation. Such multiplicity of action induced by non-steroidal anti-inflammatory agents [90, may have therapeutic advantages, but limits our ability 120]. Angiogenesis inhibitors can prevent female reproto demonstrate the roles of angiogenesis in synovitis. duction and have been proposed as potential contracepTargeting individual angiogenic pathways provides tive agents [121] . The teratogenic and abortifacient one approach to the selective inhibition of pathological, potentials of anti-angiogenic agents are of concern in rather than physiological, angiogenesis. Different pathwomen of child-bearing age. Mice lacking genes for ways may be important in angiogenesis under different VEGF or its receptors die in utero with major cardiovascircumstances. bFGF-enhanced angiogenesis is dependcular abnormalities [122] [123] [124] . Thalidomide, a wellent on integrin a v b 3 , whereas VEGF-enhanced angiogenknow teratogenic agent, has anti-angiogenic activity esis requires integrin a v b 5 [136 ] . A variety of factors that stimulate plasma extravasation appear to enhance [125] .
angiogenesis through pathways which involve nitric growth, bone and cartilage destruction, and ossification of articular cartilage and osteophytes. Angiogenesis also oxide. Such factors include VEGF and substance P [14, 137] . Vascular growth can be inhibited by antagonizing has many beneficial actions during the repair of injured tissues and the normal female reproductive cycle. Several the specific interactions between growth factors and their receptors [138] . Inhibition of individual factors or lines of evidence indicate that inhibition of angiogenesis may be a productive therapeutic strategy in human common pathways may be less prone to adverse clinical events than may be expected with global inhibitors of arthritis. Future studies should address the specific pathways that mediate pathological angiogenesis. Measured angiogenesis.
Further research is required to determine which angiooutcomes should reveal the effects of interventions on angiogenesis, as well as clinical efficacy of consequence genic pathways are important in the increased angiogenesis observed in various tissues in the inflamed joint.
to the patient. Major advances in our understanding of angiogenesis have been catalysed by recent research in The angiogenic factors that are generated early during the acute inflammatory response differ from those which oncology, wound healing and vascular biology. However, the inflamed joint differs in many respects are upregulated during chronic inflammation ( Table 1) . For example, substance P is generated and released from tumours and healing tissues. Angiogenesis is a complex process rather than a single entity, and our during acute inflammation, but may be depleted in chronically inflamed tissues [9, 139] . On the other hand, increasing understanding of the various roles of vascular growth raises the exciting possibility of novel therapeutic VEGF is present at low levels in normal synovium, but is upregulated during chronic inflammation [19, 59] . strategies in human arthritis. Different factors may therefore be important in the initiation and the maintenance of angiogenesis. The pathways that mediate vessel growth in early arthritis References may differ from those in persistent synovitis. The regula- 
